15 drug(s) with this reaction
219,881 total reports
Drug Ineffective has been reported as an adverse reaction across 15 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 219,881 adverse event reports mention drug ineffective in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with drug ineffective, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have drug ineffective listed in their FDA adverse event reports, sorted by report count:
In addition to drug ineffective, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
15 drug(s) manufactured by Abbvie Inc have drug ineffective listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, UPADACITINIB, RISANKIZUMAB-RZAA, and others.
There are a combined 219,881 reports of drug ineffective across 15 Abbvie Inc drug(s) in the FDA adverse event database.